RUA Life Sciences
Ticker: RUA Exchange: AIM www.rualifesciences.com

RUA Life Sciences is a holding company for a group of medical device businesses focused on the exploitation of the world's leading long-term implantable biostable polymer (Elast-EonTM).

Review of interims, issue, and strategic update

RUA have announced its interim results ending 30 September 2023 and together with the previous trading update, strategy update and fundraising announcement, there were few surprises. With the fundraising completed our model indicates a pathway to profitability and we publish our nearer-term financial forecasts out to YE 2025. Following on from RUA’s strategy update, we have also adjusted our valuation.

In addition to the product valuation changes reflecting RUA’s strategy update, we have incorporated the cash raised and the shares issuance into our valuation. As a result, our fair value has changed from £120.3m or 542p per share to £65.5m or 106p per share.

 

 
Download as a PDF file
26810392321 - rua-life-sciences
Return to RUA Life Sciences

Register to be first

Get research on the companies that interest you straight to your inbox

Register For Updates